True Bearing Diagnostics, INC.

TruCAD Steps to Market


• TruCAD patent application and licensing completed 2017.


• TruCAD pre-application submission and meeting with the FDA underway in late 2017.


• Pivotal TruCAD validation study launched in 2017 and targeted to be completed by year-end 2018. 


• True Bearing’s Capital Raise goal for TruCAD is $2-3 Million USD for 2018, and $7-10 M USD for 2019.


• TruCAD estimated to reach medical market in early 2019.